24/7 Patient Assistance: 760-405-8205

Ann Raldow, MD

Radiation Oncologist

Write a review
Doctor's profile photo

Request a call back

Conditions Treated Laryngeal Cancer Lung Cancer Ovarian Cancer Pericardial Mesothelioma Peritoneal Mesothelioma Pleural Mesothelioma Testicular Mesothelioma

specialties & services

  • Bio & Insurance Information

    Dr. Ann Raldow is a specialist in Radiation Oncology and is based in Los Angeles, California. She graduated from the Yale University School of Medicine and then did her internship at the Memorial Sloan-Kettering Cancer Center, followed by which she pursued her residency in Radiation Oncology at the Harvard Medical School. Over the course of her career of five years, Dr. Raldow has contributed to multiple clinical research publications. At present, she is affiliated with the Massachusetts General Hospital, UCLA Medical Center, and University of California –Los Angeles Medical Center.

  • Education & Training


    Yale University

    Medical School


    Memorial Sloan-Kettering Cancer Center



    Harvard Medical School


  • Board Certifications

    American Board of Radiology - Radiation Oncology

  • Hospital & Practice

    Massachusetts General Hospital

    Languages: English/Spanish

    (617) 726-2000

    165 Cambridge St

    Boston, Massachusetts 02114

    Read More

    UCLA Medical Center, Santa Monica

    Languages: English/Spanish

    (424) 259-6000

    1250 16th St

    Santa Monica, California 90404

    Read More

    University of California - Los Angeles Medical Center

    Languages: English/Spanish

    (310) 794-7953

    10833 Le Conte Ave

    Los Angeles, California 90095

    Read More
  • Publications & Memberships

    Dr. Ann Raldow has contributed to 3 publications.

    Short-course androgen deprivation therapy and the risk of death from high-risk prostate cancer in men undergoing external beam radiation therapy and brachytherapy.

    Raldow AC, Zhang D, Chen MH, Braccioforte MH, Moran BJ, D'Amico AV; Brachytherapy. 2015 Nov-Dec.

    See more >>

    Cost Effectiveness of the Oncotype DX DCIS Score for Guiding Treatment of Patients With Ductal Carcinoma In Situ.

    Raldow AC, Sher D, Chen AB, Recht A, Punglia RS; J Clin Oncol. 2016 Sep 12.

    See more >>

    Establishing Cost-Effective Allocation of Proton Therapy for Breast Irradiation.

    Mailhot Vega RB, Ishaq O, Raldow A, Perez CA, Jimenez R, Scherrer-Crosbie M, Bussiere M, Taghian A, Sher DJ, MacDonald SM; Int J Radiat Oncol Biol Phys. 2016 May 1.

    See more >>